Health

Cofepris warns of illegal sale of tirzepatide without sanitary registration in Mexico

Cofepris alerts to tirzepatide sold online without sanitary registration: named brands, health risks and how to verify an authorized supplier.

Pluma inyectable y vial de tirzepatida sobre mostrador de farmacia

The Federal Commission for the Protection against Sanitary Risks (Cofepris) issued a risk notice on October 26, 2026 over the illegal sale in Mexico of products containing tirzepatide, the active ingredient in Mounjaro, in formats such as vials, injectable solutions, pre-filled pens, drops and patches. None of those versions holds a sanitary registration for distribution in the country.

The warning follows an earlier alert from February 9, 2026, released with the Federal Consumer Protection Agency (Profeco) on March 11, which identified three brands without sanitary authorization: Rapha, Dr. Pen and Peptide Xperts. According to El Universal, those products were offered in drops, patches, vials and pre-filled syringes through e-commerce, websites and mobile apps, at below-market prices and without a prescription. For clinics, pharmacies and wellness platforms, the precedent matters: tirzepatide is a prescription-only product under article 226 of the General Health Law, and Forbes México reported that its use without supervision can cause overactivity in organs such as the liver or pancreas.

The October notice describes four irregularities: products that do not always contain the tirzepatide they advertise on the label, incorrect doses, undeclared harmful substances and counterfeit formats. It also notes that manufacturing, storage and transport conditions are unknown, so quality, safety and efficacy are not guaranteed. For an operator, the risk does not end at the box: a supplier without sanitary documentation places the business at the last link of an irregular sale and exposed to a possible complaint. Cofepris recommends verifying the registration in the Visor de Registros de Medicamentos, suspending use of any product bought outside authorized channels and reporting adverse reactions through VigiRam or at [email protected]. The authority also asked buyers to check that the pharmacy or platform has a physical address in Mexico and valid sanitary documentation.

The data leaves a concrete question for anyone who sells, prescribes or recommends these treatments: where did the product come from and what sanitary registration backs it. Cofepris keeps its sanitary complaint channels open to locate establishments and distributors.

This article was drafted with the assistance of artificial intelligence from verified sources and reviewed by a human editor before publication.

Sources